Home / Abrocitinib / Czechia
CZ ATC D11AH08 · updated 2 Nov 2026
Abrocitinib shortage in Czechia
Is there an Abrocitinib shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Abrocitinib product is reported short in Czechia, the first since 30 Apr 2024. The company estimate for the return is 31 Dec 2026. Main reason: commercial decision or withdrawal.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | CIBINQO 50MG 50MG TBL FLM 28 | Pfizer Europe MA EEIG, Bruxelles | 30 Apr 2024 | 31 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.